Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0247 Transporter Info | ||||
| Gene Name | SLC29A1 | ||||
| Transporter Name | Equilibrative nucleoside transporter 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Dipyridamole Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 3108 | ||||
| Docking Score | -13.857 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C24H40N8O4 | ||||
| Molecular Weight | 504.6 | ||||
| Canonical SMILES |
C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
|
||||
| InChI |
InChI=1S/C24H40N8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30/h33-36H,1-18H2
|
||||
| InChIKey | IZEKFCXSFNUWAM-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 0.7 | Rotatable Bond Count | 12 | |
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 12 | ||
| Xenobiotic Name | Lidoflazine Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 3926 | ||||
| Docking Score | -12.284 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C30H35F2N3O | ||||
| Molecular Weight | 491.6 | ||||
| Canonical SMILES |
CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CCCC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
|
||||
| InChI |
InChI=1S/C30H35F2N3O/c1-22-5-3-6-23(2)30(22)33-29(36)21-35-19-17-34(18-20-35)16-4-7-28(24-8-12-26(31)13-9-24)25-10-14-27(32)15-11-25/h3,5-6,8-15,28H,4,7,16-21H2,1-2H3,(H,33,36)
|
||||
| InChIKey | ZBIAKUMOEKILTF-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 6 | Rotatable Bond Count | 9 | |
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 5 | ||
| Xenobiotic Name | Ticagrelor Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 9871419 | ||||
| Docking Score | -11.609 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C23H28F2N6O4S | ||||
| Molecular Weight | 522.6 | ||||
| Canonical SMILES |
CCCSC1=NC(=C2C(=N1)N(N=N2)[C@@H]3C[C@@H]([C@H]([C@H]3O)O)OCCO)N[C@@H]4C[C@H]4C5=CC(=C(C=C5)F)F
|
||||
| InChI |
InChI=1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1
|
||||
| InChIKey | OEKWJQXRCDYSHL-FNOIDJSQSA-N | ||||
| Pharmaceutical Properties | Xlogp | 2 | Rotatable Bond Count | 10 | |
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 12 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.